Want to join the conversation?
$REGN and $AZN's unit MedImmune said they have entered into a licensing agreement whereby $REGN will use MedImmune's pyrrolobenzodiazepine (PBD)-based warhead and linker technology to produce antibodydrug conjugates (ADCs) as potential cancer treatments.
People seem to be cold about the $HAL earnings! Honestly, I expected more stock action by now.
$TSLA's Musk says Neuralink will take on AI prominence. Apparently, he wants to avoid a "Terminator" kind situation.
$JCP shares rebounded and now in green territory after saying it will hire 800 consultants as part of a beauty expansion that will include 70 new Sephora store-in-store locations.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.